Niksan Pharmaceutical is world's leading manufacturer, trader, exporter and supplier of the Beclomethasone Dipropionate API and Beclomethasone Dipropionate formulations. Niksan Pharmaceutical manufactures large quantity of Beclomethasone Dipropionate API and finished products in Ankleshwar, Gujarat, India. Niksan Pharmaceutical and Niksan group companies are the largest manufacturers and suppliers of Beclomethasone Dipropionateproducts.
Niksan Pharmaceutical exporting very big quantity of the fines quality products of Beclomethasone Dipropionate in all over world for many years in countries like United Kingdom, Canada, United States,Italy, Netherlands,New Zealand, Kenya, Puerto Rico, Hong Kong, Pakistan, Belgium, Nigeria,Lebanon, Bangladesh, Tunisia, Australia, Latvia, Morocco, UAE, Algeria,Ireland, France, Israel, Philippines, Taiwan etc.
Niksan Pharmaceutical also supplies large quantity of Beclomethasone Dipropionate products in Indian states like Gujarat, Haryana, Rajasthan, Madhya Pradesh, Kerala,Tamilnadu, Delhi, Bihar, Uttar Pradesh, Assam, Goa, Hyderabad, Telangana, Mizoram, Sikkim etc.
Beclomethasone Dipropionate belongs to the corticosteroid class of medicine. Beclomethasone Dipropionate is widely used in the treatment of breathing problem, chest pain, wheezing, coughing and asthma. Beclomethasone Dipropionate is used in treatment of the coughing problem caused by asthma in adult and also children.
SYNONYMS: Beclometasone Dipropionate,Beclometasone dipropionato, Beclomethasone dipropionate
IUPAC NAME:2-[(1R,2S,10S,11S,13S,14R,15S,17S)-1-chloro-17-hydroxy-2,13,15-trimethyl-5-oxo-14-(propanoyloxy)tetracycloheptadeca-3,6-dien-14-yl]-2-oxoethyl propionate
CAS NO: 5534-09-8
MOLECULAR MASS: 521.042 g/mol
STORAGE CONDITIONS: Store in room temperature, away from heat and humidity.Do not put Beclomethasone Dipropionate in bathroom or kitchen. Keep away from children and pets.
HOW TO USE: Beclomethasone Dipropionate isan inhalation medicine. Inhale the medicine 2 times per day. If you prescribed 2 puffs, take one dose and wait for 1-2 minutes for the second dose. Gargle and wash your mouth with water to prevent infection.
HOW BECLOMETHASONE DIPROPIONATE WORKS: Beclomethasone Dipropionate reduce the swelling in the airway caused by the infection and also inhibit the irritation in the airway and by this process it makes lungs to breathe easy. Beclomethasone Dipropionate is used for the long term treatment of asthma.
PHARMACOKINETICS: Beclomethasone Dipropionate absorbed in body after the inhalation or by the I.V. dose. Almost 94-96% of drug binds with the plasma protein. The half-life inhaled medicine is 0.5 hours. Half-life of I.V. dose is between 8.8-5.7 hours. Less than Beclomethasone Dipropionate drug is excreted unchanged in urine.
Side effects: Nausea, vomiting, dry mouth, Saur mouth, headache, bitter taste are the common side effects of the medicine.The medication some time causes breathing problem, yeast infection, fever,chills, weakness, ear pain. Tell your doctor if you see side effects like hair growth, mood change, puffy face, vision problem, eye problem, weakness, skin thinning, patches on tongue.
PRECAUTIONS: Tell your pharmacist if you are allergic to the Beclomethasone Dipropionate. Tell your doctor about your medical history if you have bone disorder, eye disease, liver disease,abdominal disease, GI problem, kidney problem. Kindly take doctor's advice if you are already using other medications. These drug causes blur vision, so kindly do not drive or operate machinery after taking the medicine.
CDSCO APPROVAL: Beclomethasone Dipropionate IP0.025% w/w + Neomycin sulphate IP 0.5% w/w cream 15.09.2010
Beclomethasone Dipropionate approved by CDSCO in India in December- 1975
Beclomethasone Dipropionate B.P. approved by CDSCO in India in February-1973
Beclomethasone Dipropionate IP 100mcg + Formoterol Fumerate Dihydrate BP Eq. to Formoterol Fumerate 6 mcgMetered Dose Inhaler approved by CDSCO in India in 05.01.2011 Beclomethasone Dipropionate 0.25mg + Econazole 10mg + Neomycin 5mg per gm of Cream approved by CDSCO inIndia in 30.01.2008
Beclomethasone Dipropionate approved by CDSCO in India in April-1974
Beclomethasone dipropionate inhaler approved by CDSCO in India in 21.12.2000
FORMULATIONS AVAILABLE IN MARKET:
Beclomethasone 0.025%w/w cream
Beclomethasone 0.025%w/v solution
Beclomethasone 0.05 %w/w gel
Beclomethasone 50 mcg tablets
Beclomethasone Dipropionate IP 100mcg + Formoterol FumerateDihydrate BP Eq. to Formoterol Fumerate 6 mcg Metered Dose Inhaler
Beclomethasone Dipropionate 0.25mg + Econazole 10mg + Neomycin 5mg per gm of Cream
Beclomethasone dipropionate inhaler
Note: Product protected by valid patents are not offered for sale in countries where such patents are still valid and its liability is at Buyers Risk
Developed and Managed by Infocom Network Private Limited.